IPO Timeline
Broker Results (T-2)
2020-07-08
Some brokers release in afternoon
Grey Market (T-1)
2020-07-09
Afternoon
HKEX Allotment (T-1)
2020-07-09
Evening
Registrar Allotment (T-1)
2020-07-09
Evening
Listing Day (T)
2020-07-10
First day of trading
Company Overview
| Stock Name | 歐康維視生物 - B |
|---|---|
| Stock Code | 01477 |
| Company Full Name | 歐康維視生物 - B |
| Industry | 醫療保健 |
| Principal Activities | 為中國眼科醫藥平臺公司，從事開發及商業化眼科療法。 |
| Listing Date | 2020-07-10 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市靜安區石門一路211號旺旺大廈502-1室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.ocumension.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 14.66 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 49.9% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 776,466,900 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 37.0 |
|---|---|
| First Day Open | HK$ 43.0 |
| First Day Change | 152.39% |
| First Day Volume | 59068800.0 |
| First Day Turnover | 2394770000.0 |
Use of Proceeds
| Use of Proceeds | 1、約427.19百萬港元（即所得款項凈額的30.00%）將用于我們的核心產品OT401； 2、約711.98百萬港元（即所得款項凈額的50.00%）將用于其他候選藥物； 3、約142.40百萬港元（即所得款項凈額的10.00%）將用于根據我們與當地政府所訂合作協議收購蘇州的制造設施； 4、約142.40百萬港元（即所得款項凈額的10.00%）將用作營運資金及用于其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
Overall Coordinators (3)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
Joint Bookrunners (3)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
Joint Lead Managers (3)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
UBS Securities Hong Kong Limited CE BIN466
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Alpha Profit Holdings Limited | 116,231,810 HKD | — | 7.48% | — | 6 months | 2021-01-10 |
| 2 | BlackRock Funds | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 3 | Boyu Capital Opportunities Master Fund | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 4 | Cormorant Asset Management, LP | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 5 | Fidelity International | 139,475,240 HKD | — | 8.98% | — | 6 months | 2021-01-10 |
| 6 | General Atlantic Singapore OT Pte. Ltd. | 77,485,430 HKD | — | 4.99% | — | 6 months | 2021-01-10 |
| 7 | HBM Healthcare Investments (Cayman) Ltd. | 23,243,430 HKD | — | 1.50% | — | 6 months | 2021-01-10 |
| 8 | Hudson Bay Master Fund LTD | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 9 | Lake Bleu Prime Healthcare Master Fund Limited | 54,242,000 HKD | — | 3.49% | — | 6 months | 2021-01-10 |
| 10 | Octagon Investments Master Fund LP | 15,495,620 HKD | — | 1.00% | — | 6 months | 2021-01-10 |
| 11 | OrbiMed Funds | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 12 | Rock Springs Capital Master Fund LP | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 13 | SCC Growth V Holdco L, Ltd. | 38,739,050 HKD | — | 2.49% | — | 6 months | 2021-01-10 |
| 14 | TLS Beta Pte. Ltd. | 77,485,430 HKD | — | 4.99% | — | 6 months | 2021-01-10 |
Directors & Management
| Chairman | 陳連勇 |
|---|---|
| Company Secretary | 阮添士;陳聽蟬 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 6 Dimensions Capital GP, LLC(18.90%);蘇州通和二期創業投資合伙企業(有限合伙)(13.23%);Boyu Capital Fund IV, L.P.(11.71%);淡馬錫控股(私人)有限公司(8.90%);The Capital Group Companies, Inc.(7.05%);蘇州通和毓承投資合伙企業(有限合伙)(5.67%) |
|---|
IPO Timeline
